In this study, we examined the distribution of fucosylated glycans in mouse intestines using a lectin, BC2LCN (N-terminal domain of the lectin BC2L-C from Burkholderia cenocepacia), as a probe. BC2LCN is specific for glycans with a terminal Fucα1,2Galβ1,3-motif and it is a useful marker for discriminating the undifferentiated status of human induced/embryonic stem cells. Apparent BC2LCN reactivity was detected in the secretory granules of goblet cells in the ileum but not those in the colon. We also found distinctive reactivity in the crypt bottom, which is known as the stem cell zone, of the colon and the ileum. Other lectins for fucosylated glycans, including Ulex europaeus agglutinin-I, Pholiota squarrosa lectin and Aleuria aurantia lectin, did not exhibit similar reactivity in the crypt bottom. Remarkably, BC2LCN-positive epithelial cells could be labeled with a niche cell marker, c-Kit/CD117. Overall, our results indicate that intestinal niche cells express distinct fucosylated glycans recognized by BC2LCN. Increasing evidence suggests that the selfrenewal and proliferation of stem cells depend on specific signals derived from niche cells. Our results highlight novel molecular properties of intestinal niche cells in terms of their glycosylation, which may help to understand the regulation of intestinal stem cells. The distinct expression of glycans may reflect the functional roles of niche cells. BC2LCN is a valuable tool for investigating the functional significance of protein glycosylation in stem cell regulation.
Introduction
The significantly rapid renewal of mammalian intestinal epithelial cells is driven by intestinal stem cells. Stem cells divide asymmetrically into one multipotent/undifferentiated stem cell and one daughter, which is known as a rapid proliferating transit-amplifying cell. Daughter cells subsequently develop into terminally differentiated epithelial cell types during the course of their upward migration along the crypt-villus axis (Bach et al. 2000; Barker, 2014) . The in vivo lineage-tracing technique and organoid culture were used to identify the leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) as the most probable marker for specifically labeling intestinal stem cells (Barker et al. 2007; Sato et al. 2011) . The activity and fate of stem cells are affected by the specific microenvironment around the cells, which is called the stem cell niche (Biswas et al. 2015) . The niche comprises subsets of cells, which provide factors that are crucial for stem cell proliferation, such as cytokines and growth factors. Characterization of the cellular and molecular constituents of the niche is important for understanding intestinal homeostasis as well as the underlying mechanisms responsible for epithelial cell differentiation and various intestinal diseases, including inflammatory bowel disease and tumorigenesis. In the small intestine, Paneth cells (PCs) are known to secrete antibacterial molecules such as lysozyme and cryptdins/defensins (Ouellette, 2010) . It has been proposed that PCs also function as niche cells by providing Wnt3a, Notch ligand and epidermal growth factor, which are essential for stem cells (Sato et al. 2011) . PCs are absent from the colon, but a recent study functionally identified c-Kit (also known as CD117)-positive cells in the crypt bottom as colonic niche cells (Rothenberg et al. 2012) . However, these colonic niche cells are not well characterized.
Glycan structures exhibit extreme complexity and diversity, depending on the tissues and cells where they are expressed. Glycans are strongly related to various physiological and pathological processes (Varki, 1993; Lowe and Marth, 2003; Ohtsubo and Marth, 2006) , and various types of fucosylated glycans are expressed in mammalian tissues. Fucosylated glycans are found in the N-/O-glycans attached to a wide variety of glycoproteins and glycolipids. The fucose (Fuc) residue can attach to a terminal galactose (Gal) residue via an α1,2-linkage and an N-acetylglucosamine (GlcNAc) residue via α1,3, α1,4 or α1,6 linkages. These fucosylated glycans play important roles in various biological events and their biosynthesis is regulated temporally and spatially by reactions with fucosyltransferases. The functional significance of fucosylated glycans with a terminal α1,2-linked Fuc (H-type glycans) has been described in multiple biological processes, including host-microbial interactions, morphogenesis and malignancy (Staudacher et al. 1999; Becker and Lowe, 2003) . Recent studies have also demonstrated their important roles in intestinal homeostasis (Goto et al. 2014; Pham et al. 2014; Pickard et al. 2014) . In these processes, the dynamic and specifically regulated expression of H-type glycans is mediated by a pair of α1,2-fucosyltransferases, FUT1 and FUT2 (Oriol et al. 1999 ). α1,2-Fucosyltransferase generates two glycan groups, which differ in terms of their terminal glycan motif, i.e., glycans with a terminal Fucα1,2 Galβ1,3-motif and those with a terminal Fucα1,2 Galβ1,4-motif (Sarnesto et al. 1992) .
The tissue and cellular localization as well as alterations of glycans can provide valuable insights into their specific roles. Lectins have been used in numerous histochemical studies to detect and discriminate a particular glycan motif, and to determine their tissue and cellular localization (Akimoto and Kawakami, 2014) . Recently, lectins have received increased attention because they can also be utilized as a valuable probe for marking a particular cell type and for evaluating cell status, such as differentiation, activation and disease progression (Okuyama et al. 2006; Tao et al. 2008; Lohr et al. 2010) . This is because the glycans produced by a cell depend on specific biological processes. Recent studies have focused mainly on the exploration of glycan-related biomarkers in reproductive medicine. The expression of certain glycans can indicate the undifferentiated status of human induced pluripotent stem cells (hiPSCs) and embryonic stem cells (hESCs) (Satomaa et al. 2009; Toyoda et al. 2011) . BC2LCN (the N-terminal domain of the lectin BC2L-C from Burkholderia cenocepacia) (Sulák et al. 2010 ) is a recently described lectin and it is a valuable tool for marking undifferentiated/pluripotent hiPSCs/hESCs (Tateno et al. 2011; Onuma et al. 2013) .
In this study, we utilized BC2LCN to examine the expression of fucosylated glycans in the mouse intestinal tract. BC2LCN specifically binds fucosylated glycans with a terminal Fucα1,2Galβ1,3-motif (Tateno et al. 2011; Onuma et al. 2013) . To obtain further insights into the significance of fucosylated glycans, especially H-type glycans, in the intestinal tract, we determined the distribution of fucosylated glycans with a terminal Fucα1,2Galβ1,3-motif in the mouse intestinal tract using BC2LCN as a probe. The reactive sites of BC2LCN were compared with those of other well-characterized lectins for fucosylated glycans and we identified the distinct reactivity of BC2LCN in a subset of cells at the bottom of the crypt. Our results demonstrate novel molecular properties of intestinal niche cells in terms of their glycosylation.
Results

Lectin fluorescent staining of the ileum
To determine the distribution of fucosylated glycans, frozen intestinal tissue sections from conventional breeding mice were subjected to immunohistochemical staining with a panel of lectins that recognize fucosylated glycans. The staining was visualized by fluorescent dyes and examined using confocal laser scanning microscopy. In the ileum, strong reactivity with BC2LCN was observed in granules in the lower part of the villi and the upper part of the crypt, which mainly contains maturing goblet cells ( Figure 1A) . In some cases, intense reactivity was also observed in matured goblet cells in the upper part of the villi. BC2LCN reactivity was also detected in a subset of epithelial cells in the crypt bottom. An enlarged image of the crypt bottom is also shown in Figure 1B . Clear signals of BC2LCN reactivity were localized on the apical side of the perinuclear intracellular region of the crypt-bottom cells. Several annulus or ribbon-like staining patterns were observed. The specificity of this staining was confirmed by the preincubation of BC2LCN with 200 mM Fuc as a hapten sugar before lectin binding. Preincubation with Fuc abolished this staining ( Figure 1C ).
Histochemical analysis was performed using well-characterized lectins specific for fucosylated glycans to characterize the observed binding sites of BC2LCN. The representative glycan motifs recognized by the lectins are shown in Table I . Ulex europaeus Fig. 1 . Lectin histochemical staining of fucosylated glycans in the mouse ileum. Mouse ileum sections were stained with biotinylated lectins for fucosylated glycans and visualized using Alexa Fluor 555-conjugated streptavidin. The signals derived from lectin binding are shown in gray, and TO-PRO-3 nuclei staining is shown in blue. The lectins used were BC2LCN (A-C), UEA-I (D), PhoSL (E) and AAL (F). Higher magnification images of the crypt-bottom regions are depicted in (B) and (C). Arrowheads indicate BC2LCN-reactive sites at the bottoms of the crypts. In (C), the BC2LCN reactivity was diminished after adding 200 mM Fuc. Scale bars; 100 µm (A, D, E and F) and 50 µm (B and C). This figure is available in black and white in print and in color at Glycobiology online.
agglutinin (UEA)-I specifically recognizes glycans with a terminal Fucα1,2Galβ1,4-motif (Baldus et al. 1996; Mollicone et al. 1996) . Strong reactivity with UEA-I was observed in the granules of goblet cells throughout the whole region of the villi ( Figure 1D ). UEA-I reactivity was also detected on the apical surface of the brush border in the villi. In the crypt bottom, the intense reactivity of UEA-I was distributed in the peripheral region of secretory granules in the crypt bottom, as reported previously in rats (Leis et al. 1997) . However, the staining pattern of UEA-I was clearly different from that of BC2LCN. Pholiota squarrosa lectin (PhoSL) was used for specifically detecting α1,6-linked Fuc attached to the innermost GlcNAc of N-glycan (Kobayashi et al. 2012) . PhoSL stained granules in the goblet cells ( Figure 1E ). PhoSL reactivity was also detected in the brush border of the villi and the peripheral region of secretory granules in the crypt bottom. Intense reactivity was observed in the serous membrane. Aleuria aurantia lectin (AAL) exhibits broader specificity against multiple types of fucosylated glycans, and its preferential glycan motifs are α1,2-linked Fuc on the terminal Gal, α1,3-/α1,4-linked Fuc on GlcNAc and α1,6-linked Fuc on the innermost GlcNAc of N-glycan (Fukumori et al. 1990; Wimmerova et al. 2003; Matsumura et al. 2009 ). Intense reactive sites of AAL were detected in the granules of goblet cells in the villi ( Figure 1F ). This staining was also observed in the brush border and the cell surfaces of intestinal muscle cells. AAL reactivity was also detected in the peripheral region of secretory granules in the crypt bottom in a similar manner to the UEA-I staining ( Figure 1D ).
Lectin fluorescent staining of the distal colon
In the distal colon, BC2LCN reactivity was observed in a small number of epithelial cells at the very bottom of the crypt ( Figure 2A ). There are fewer secretory cells in the colonic crypt bottom (Altmann, 1983) , but BC2LCN reactivity was observed in an apically located, apparently granule-like component ( Figure 2B ). By contrast, these granules reacted rarely in the mature goblet cells in the upper part of the crypt. Instead, cytoplasmic BC2LCN binding was observed in mature goblet cells. BC2LCN reactivity was also observed in the luminal surface of enterocytes. Similar to the ileum, this reactivity disappeared after 200 mM Fuc was added as a hapten sugar ( Figure 2C ).
To characterize the observed binding sites of BC2LCN, histochemical analyses were performed using other lectins specific for fucosylated glycans, similar to those in the ileum. Much of the BC2LCN staining did not overlap with these lectins. In contrast to the BC2LCN staining, UEA-I reactivity was observed in the granules of goblet cells ( Figure 2D ), where the reactivity was very clear and the signal was intense. However, this reactivity was not observed in the crypt bottom. Intense PhoSL reactivity was observed on the basal surfaces of cryptic epithelial cells ( Figure 2E ). The goblet cell granules and the luminal surface of enterocytes were also reacted. Consisted with a previous study (Hurd et al. 2005) , AAL reactivity was evident in the granules of goblet cells and the luminal surface of enterocytes ( Figure 2F ). The basal surfaces of cryptic epithelial cells also reacted weakly.
Histochemical characterization of BC2LCN-positive cells in the ileal crypt bottom
To determine the cell types that express the fucosylated glycans recognized by BC2LCN (BC2LCN-glycans), we conducted a series of immune-fluorescent staining tests using BC2LCN and antibodies for the defined markers of intestinal epithelial cells.
In the ileum, characteristic BC2LCN reactivity was detected in the crypt bottom (Figure 1 ) in the so-called stem cell zone where the stem cells and PCs reside (Barker et al. 2007; Sato et al. 2011) . To examine whether BC2LCN-glycans are expressed in these cells, we attempted to identify the BC2LCN-positive cells using an antibody for lysozyme (a marker for PCs) (Bry et al. 1994; Ouellette, 2010) , c-Kit/CD117 (a marker for niche cells) (Rothenberg et al. 2012) or Lgr5 (a marker for stem cells) (Barker et al. 2007) . Their coexpression was examined using confocal laser scanning microscopy. PCs were labeled with anti-lysozyme antibody as expected. The costaining patterns demonstrated that the BC2LCN reactivity was localized in the PCs ( Figure 3A ). In the PCs, the BC2LCN reactivity was not localized in the secretory granules but instead it was observed in another intracellular compartment, which was probably the Golgi apparatus because the observed annulus or ribbon-like staining patterns was typical of this region. In the ileum, PCs were also labeled with c-Kit ( Figure 3B ), as shown previously (Rothenberg et al. 2012) . Thus, we demonstrated that the BC2LCN-positive cells were labeled with c-Kit. Fucα1,6 on the innermost GlcNAc of N-glycan Aleuria aurantia AAL Fucα1,6 on the innermost GlcNAc of N-glycan Fucα1,2Galβ1,4-Galβ1,4 (Fucα1,3) GlcNAcGalβ1,3 (Fucα1,4) GlcNAc- Fig. 2 . Lectin histochemical staining of fucosylated glycans in the mouse distal colon. Mouse distal colon sections were stained with biotinylated lectins for fucosylated glycans and visualized using Alexa Fluor 555-conjugated streptavidin. Signals derived from lectin binding are shown in gray and TO-PRO-3 nuclei staining is shown in blue. The lectins used were BC2LCN (A-C), UEA-I (D), PhoSL (E) and AAL (F). Higher magnification images of the cryptbottom regions are depicted in (B) and (C). Arrowheads indicate BC2LCN-reactive sites at the bottoms of the crypts. In (C), BC2LCN reactivity was diminished after adding 200 mM Fuc. Scale bars; 100 µm (A, D, E and F) and 50 µm (B and C). This figure is available in black and white in print and in color at Glycobiology online. D Sugahara et al.
To further characterize BC2LCN binding properties, doublestaining experiments were also conducted using UEA-I. UEA-I reactivity was observed in PCs labeled with lysozyme ( Figure 3D ). The PCs were also labeled with anti-c-Kit antibody ( Figure 3E ). It was notable that in the PCs, the UEA-I reactivity was localized in the peripheral region of the secretory granules. Hence, it was obvious that BC2LCN and UEA-I recognized distinct intracellular compartments of PCs. BC2LCN and UEA-I also reacted with the granules of the goblet cells.
Some crypt-bottom cells were labeled with Lgr5 and were located adjacent to the PCs ( Figure 3C and F). The Lgr5 reactivity observed in these cells was much weaker than that in the epithelial cells located directly above the PCs, i.e., transit-amplifying cells. It has been reported that stem cells can be morphologically distinguished from granule-rich PCs based on their wedge-like-shaped nuclei, which point toward the crypt lumen (Barker et al. 2007; Sato et al. 2011) . Indeed, some crypt-bottom cells with wedge-likeshaped nuclei were labeled with Lgr5 ( Figure 3C and F). These stem cells are known to be intercalated with PCs and they lack secretory granules. According to the other images shown in Figure 3 , several crypt-bottom cells also possessed these features and thus were considered to be stem cells. However, BC2LCN and UEA-I reactivity was not observed in these cells. Thus, these stem cells appeared not to express fucosylated glycans recognized by BC2LCN and UEA-I.
Subcellular localization of the BC2LCN-glycans in PCs
To determine the subcellular localizations of BC2LCN-glycans in PCs, we conducted a series of co-immunostaining analyses using BC2LCN and antibodies for markers of ER/Golgi sub-compartments by confocal laser scanning microscopy. As shown in Figures 1 and 3,   BC2LCN staining obtained a typical staining pattern in the Golgi apparatus. In fact, the BC2LCN signals were co-localized with a trans-Golgi marker, TGN38 ( Figure 4A ). Much of the BC2LCN staining was surrounded by cis/medial-Golgi markers, GM130 ( Figure 4B) . A small amount of BC2LCN staining appeared to overlap with the Golgi compartment marked by anti-GM130 antibody. Furthermore, the BC2LCN staining was dissociated from an ER marker, calnexin ( Figure 4C ). These staining patterns suggest that most BC2LCN-reactive sites were associated with the trans-Golgi cisternae/network.
Histochemical characterization of BC2LCN-positive cells in the colonic crypt bottom
In the distal colon, BC2LCN-reactive sites were localized in goblet cells in the upper part of the crypt and in a small population of epithelial cells at the crypt bottom (Figure 2A and B) . Similar to the ileum, we attempted to identify the BC2LCN-reactive epithelial cells in the crypt bottom. We performed immune-fluorescent tests using BC2LCN and an antibody for MUC2 (a marker for goblet cells) (Kim and Ho, 2010) , c-Kit/CD117 (a marker for intestinal niche cells) (Rothenberg et al. 2012 ) and Lgr5 (a marker for intestinal stem cells) (Barker et al. 2007; Sato et al. 2011) . Their co-expression was examined by confocal laser scanning microscopy. The subcellular localizations of BC2LCN-reactive sites in the ileal crypt bottom were analyzed using confocal microscopy. Mouse ileum sections were co-stained with biotinylated BC2LCN (magenta) and antibodies for ER/ Golgi markers (green). The markers used were TGN38 for a trans-Golgi compartment (A), GM130 for a cis/medial-Golgi compartment (B) and calnexin for endoplasmic reticulum (C). TO-PRO-3 nuclei staining is shown in blue. Enlarged images of representative crypt bottom are depicted. Inserts show enlarged views of the boxed regions. The dotted line denotes a crypt unit containing several PCs. Scale bars; 10 µm. This figure is available in black and white in print and in color at Glycobiology online.
As shown in Figure 5A , goblet cells were marked by strong reactivity to the anti-MUC2 antibody in their secretory granules. MUC2 expression was observed throughout the crypt where the signal intensity and frequency decreased gradually toward the bottom. The staining almost disappeared at the very bottom. In contrast, the secretory granules did not react with BC2LCN irrespective of their positions in the crypt. Co-localized signals derived from BC2LCN and the anti-MUC2 antibody were not observed. However, the cytoplasm of the goblet cells appeared to react with BC2LCN. In the crypt bottom, BC2LCN reactivity was also found in a small population of epithelial cells. This reactivity appeared to be included in the secretory granules of these cells. It was notable that the anti-MUC2 antibody did not react at all with the BC2LCN-reacting granules. Similar to the ileum, colonic stem cells and their niche cells are known to be positioned at the bottom (Barker et al. 2007; Sato et al. 2011 ). According to co-staining using the anti-c-Kit antibody, clear c-Kit reactivity was observed on the cell surfaces of the BC2LCN-positive cells at the crypt bottom ( Figure 5B ). The distal colon had the typical staining pattern of Lgr5 ( Figure 5C and F) , and these Lgr5-labeled epithelial cells were located at the crypt bottom, as described in previous studies (Barker et al. 2007; Sato et al. 2011; Rothenberg et al. 2012 ). These results indicate that BC2LCN-positive cells were adjacent to the Lgr5-labeled stem cells. BC2LCN reactivity was not observed in these stem cells. It was notable that the BC2LCN reactivity was limited to only a small subset of the c-Kit-positive cells ( Figure 5B) .
We also performed co-staining using UEA-I and epithelial cell markers ( Figure 5D-F) . According to co-staining using the anti-MUC2 antibody, most signals were co-localized in the granules of goblet cells ( Figure 5D ). UEA-I reactivity was present in the granules positioned in the upper parts of the crypt, whereas negative results were obtained in the lower crypt. Epithelial cells marked with c-Kit or Lgr5 did not react with UEA-I at the bottom ( Figure 5E and F) .
Discussion
We demonstrated the unique binding property of BC2LCN in the intestinal tract and its value as a probe for investigating fucosylated glycans in histochemical study. Previous detailed analyses of the glycan specificity of BC2LCN support its specific binding to glycans with a terminal Fucα1,2Galβ1,3-motif (Tateno et al. 2011; Onuma et al. 2013) . The same studies also indicated that BC2LCN has an affinity for another fucosylated glycan, Lewis b glycan (Fucα1,2Galβ1,3 (Fucα1,4) GlcNAcβ-). However, Lewis b glycan is known to be absent from mouse tissues because of the lack of the active α1,3-fucosyltransferase responsible for its biosynthesis (Dupuy et al. 2002) . Thus, we expected that BC2LCN staining would specifically reflect the expression and distribution of glycans with a terminal Fucα1,2Galβ1,3-motif in this study.
The observed binding sites of BC2LCN were different from those of other well-characterized Fuc-specific lectins, UEA-I, AAL and PhoSL. In particular, the unique reactivity of BC2LCN was observed in the intracellular region of PCs in the ileum. Consisted with a previous study (Bry et al. 1994) , UEA-I reactivity was localized in the secretory granules (Figure 3) . By contrast, BC2LCN reactivity was restricted to the Golgi apparatus, but not the secretory granules. In addition, the Golgi distribution of the BC2LCN-glycans was observed only in PCs and not in other small intestinal epithelial cells. BC2LCN-glycans are assumed to be Golgi resident because the BC2LCN reactivity was not detected in the secretory granules or on the cell surfaces of PCs. The α1,2-fucosyltransferase appears to control glycan biosynthesis because glycans with a terminal Fucα1,2Galβ1,3-motif were attached specifically to a certain Golgi protein. This regulated expression might be related to a particular role of glycans with a terminal Fucα1,2Galβ1,3-motif in the PCs. The trans-Golgi cisternae/network plays a pivotal role in the processing and sorting of proteins (Guo et al. 2014) . The functional significance of BC2LCN-glycans is still uncertain, but they may be involved in these processes.
In the distal colon, we found that unique BC2LCN reactivity was localized in a small population of crypt-bottom cells (Figures 2  and 5 ). The BC2LCN-reactive sites were included in the secretory granules of the c-Kit-labeled niche cells (Rothenberg et al. 2012) . In contrast, BC2LCN staining was not observed in the granules of goblet cells in the upper part of the crypt. The other lectins used in the present study did not exhibit reactivity in the crypt-bottom cells, including c-Kit-labeled cells (Figures 2 and 5) . Thus, the glycans with a terminal Fucα1,2Galβ1,3-motif seemed to be the only fucosylated glycan expressed in the niche cells. By contrast, other types of This study also obtained novel findings regarding the distribution of glycans with a terminal Fucα1,2Galβ1,3-motif in colonic goblet cells (Figure 2) . The BC2LCN staining in goblet cells was significantly different from that observed in the ileum. BC2LCN intensely stained the secretory granules in ileal goblet cells, but not their intracellular region (Figure 1) . In colonic goblet cells, BC2LCN reacted with the cytoplasm in a diffuse manner, but not with their secretory granules. This contrasted greatly with the reactivity of the other Fuc-specific lectins shown in this study (Figure 2 ) and previous studies (Imai et al. 2003; Hurd et al. 2005; Liquori et al. 2012) , as UEA-I and AAL exhibited prominent reactivity against granules, whereas these lectins had little or weaker reactivity in their intracellular region. Taken together with the co-staining results shown in Figure 5 , these data indicated that goblet cell mucins are heavily fucosylated but lack fucosylated glycans with a terminal Fucα1,2Galβ1,3-motif.
Colonic niche cells are not well-characterized, mainly due to the lack of morphological and molecular features distinguishing them from other epithelial cell types. Rothenberg et al. (2012) showed that the expression of c-Kit is a common molecular feature of the niche cells in the small intestine and the colon (Rothenberg et al. 2012) . In the present study, we detected the expression of BC2LCN-glycans in the niche cells in the colon as well as in the ileum. Thus, the expression of BC2LCN-glycan may be considered as another feature of intestinal niche cells. Moreover, BC2LCN is an attractive candidate for a niche cell marker in the mouse colon. The unique reactivity of BC2LCN in the colonic crypt bottom thus may be useful for identifying and characterizing intestinal niche cells.
We found that BC2LCN reactivity was a common feature of the niche cells in the ileum and distal colon, but we also detected important differences in the intracellular distributions of BC2LCN-glycans in these cells. BC2LCN-reactive sites were localized in the Golgi apparatus in the ileum and in the secretory granules in the colon. We also found differences in the frequency of detection of BC2LCN-positive cells in the crypt bottom. Multiple Lgr5-labeled stem cells and c-Kit-labeled cells were distributed in the colonic crypt bottom, but only a limited number of these c-Kit-labeled cells were stained by BC2LCN ( Figure 5 ). By contrast, most of the PCs were reactive to BC2LCN in the ileum (Figure 3) . A possible explanation for the limited detection of BC2LCN reactivity in colonic niche cells may be the transient expression of BC2LCN-glycans. The transient expression of Notch ligands (Delta-like Protein (DLL) 1 and 4) was also demonstrated in the same niche cell population (Shimizu et al. 2014) . These ligands are essential for the correct proliferation and differentiation of stem cells (Pellegrinet et al. 2011) . Similarly, the temporal expression of BC2LCN-glycans might also be related to these processes. Furthermore, it is possible that the limited expression of glycans could reflect the heterogeneity of the c-Kit-labeled cells. It is well known that protein glycosylation varies according to the state of a cell, such as cell differentiation and extracellular/intracellular signaling (Tao et al. 2008; Reis et al. 2010; Furukawa et al. 2013; Hamouda et al. 2013) . The limited expression of the BC2LCN-glycans might indicate the presence of different cell subsets or distinct cellular states among the c-Kit-positive niche cells. Further studies of the expression of BC2LCN-glycans in a variety of physiological and pathological conditions will provide novel insights into niche cell biology and elucidate the functional significance of this observation.
Lgr5 immunostaining in the distal colon obtained the typical staining pattern of Lgr5 (Figure 5 ), whereas that in the ileum did not produce the stem cell-specific staining pattern (Figure 3) . Some crypt-bottom cells adjacent to PCs were labeled by Lgr5 as expected, but the transit-amplifying cells located directly above the PCs were also labeled. The utility of Lgr5 expression as a specific marker for stem cells was originally demonstrated using special genetically modified mice (Lgr5-EGFP-IRES-creERT2 knock-in allele) (Barker et al. 2007; Sato et al. 2011) . However, it has been suggested that immunostaining for Lgr5 is inconsistent with the Lgr5 expression patterns observed in the Lgr5-EGFP knock-in mice. Thus, as shown in the small intestines of mice (May et al. 2009 ) and humans (Becker et al. 2008) , Lgr5 immunostaining often identifies crypt-bottom stem cells and transit-amplifying cells. Therefore, as shown in Figure 3 , we also considered the positional and morphological features detected in studies using Lgr5-EGFP knock-in mice to identify the stem cells (Barker et al. 2007; Sato et al. 2011) . The identification of ileal stem cells remains ambiguous due to the commercial unavailability of an anti-Lgr5 antibody with high specificity and affinity, but we clearly found that the crypt-bottom epithelial cells, excluding the PCs, were not stained by BC2LCN or UEA-I. Our results showed that various types of fucosylated glycans were expressed in the intestinal epithelial cells, but these stem cells seemed to lack the expression of fucosylated glycans. The results of this study indicate the unique glycosylation properties of intestinal stem cells.
The unique and limited expression of BC2LCN-glycan in intestinal niche cells could be related to their specific roles. It is well known that glycans play major biological roles by significantly affecting the functions of glycoproteins. For example, attachment of a particular glycan has a role in determining intracellular localization of their carrier proteins. The heavily glycosylated domain of TGN38, a maker for the trans-Golgi network, is supposed to be related to the determination of its Golgi localization (Ponnambalam et al. 1996) . Although the precise mechanism by which the Golgi localization is determined by the attachment of the glycan is still unclear, this suggests that protein glycosylation is involved in determining the Golgi localization of a carrier protein. In this study, we demonstrated that the expression of BC2LCN-glycans is restricted in the Golgi apparatus of PCs. It is possible that attachment of BC2LCN-glycans contributes to a Golgi localization determinant in PCs. Identification of carrier proteins of BC2LCN-glycans would be crucial to examine this possibility and understand the roles of BC2LCN-glycans in PCs. We also performed lectin blot analysis and demonstrated the attachment of BC2LCN-glycans to intestinal proteins (Supplementary data, Figure S1 ). The different binding patterns of BC2LCN and UEA-I indicate that BC2LCN-glycans are attached to a different subset of proteins compared with those that carry UEA-I-glycans. BC2LCN-glycans could have unique roles that differ from those of UEA-I-glycans by regulating the functions of their carrier proteins.
In conclusion, we demonstrated the distinct and restricted expression of glycans with a terminal Fucα1,2Galβ1,3-motif in the mouse intestinal tract. BC2LCN staining indicated the characteristic expression of fucosylated glycans in intestinal niche cells. The limited and regulated expression of the fucosylated glycans in niche cells suggests that these glycans are involved in some function of the stem cell niche as well as in the homeostasis of the intestinal epithelium. Further studies of the changes in expression of the glycans under pathological conditions, such as experimental enteritis, may help to elucidate their biological roles and functional significance.
Materials and methods
The animal experiments were approved by the Committee on Animal Experimentation of Kyorin University, Japan (approval number 148). Tissues of Jcl:ICR mice (8 weeks of age, male; Clea Japan, Tokyo, Japan) were prepared from the distal part (ileum) of the small intestine and distal half of the colon. Intestinal tissues were fixed in 4% paraformaldehyde at 4°C for 2 h, cryoprotected in phosphate-buffered saline (PBS) containing 10% sucrose, and embedded in optical cutting temperature compound (Sakura Finetek, Tokyo, Japan). Sections measuring 10 μm in thickness were prepared on a cryostat and placed on FRONTIER-coated glass slides (Matsunami Glass Industries, Osaka, Japan).
For lectin staining, the air-dried sections were washed with PBS and blocked with 4% (w/v) Block Ace (DS Pharma Biomedical, Osaka, Japan) for 15 min at room temperature. Sections were incubated with biotinylated lectins (5 μg/mL) for 2 h at room temperature. Commercially biotinylated UEA-I and AAL were obtained from Vector Laboratories (Burlingame, CA). Biotinylated PhoSL was prepared as reported previously (Kobayashi et al. 2012) . Recombinant BC2LCN (Wako Pure chemical Industries, Osaka, Japan) was labeled with biotin using a Biotin-labeling kit-NH2 (Dojindo Molecular Technologies, Kumamoto, Japan). After washing with PBS, the tissues were incubated with Alexa Fluor 555-conjugated streptavidin (1:1000; Life Technologies, Carlsbad, CA) for 1 h at room temperature. TO-PRO-3 (Life Technologies) was used for nuclear staining. All of the stained sections were mounted with SlowFade Diamond antifade reagent (Life Technologies). The specificity of the reaction was examined by omitting the biotinylated lectins. To show the specific reactivity of BC2LCN staining, sections were incubated with the lectin in the presence of an excess amount of fucose (200 mM) as a hapten sugar. Background staining was negligible in all of the staining experiments. Images were obtained with an LSM510 confocal microscope (Carl Zeiss, Jena, Germany).
For double-staining using lectin and antibody, the air-dried sections were washed with PBS and blocked with 4% (w/v) Block Ace (DS Pharma Biomedical) for 15 min at room temperature. Sections were incubated with biotinylated UEA-I or BC2LCN (5 μg/mL) for 2 h at room temperature. Sections were washed with PBS and incubated with an antibody for 2 h at room temperature. The following antibodies were used: anti-lysozyme (1:100; clone EPR2994(2), ab108508, Abcam, Cambridge, UK), anti-CD117/c-Kit (1:100; AF1356, R&D Systems, Minneapolis, MN), anti-Lgr5/GPR49 (1:100; AP03046PU-N, Acris Antibodies Gmbh, Herford, Germany), anti-TGN38 (1:100; NBP1-03495, Novus Biologicals, Littleton, CO), anti-GM130 (1:100; clone EP892Y, ab52649, Abcam), anti-calnexin (1:700; clone C3, GTX109669, GeneTex, Irvine, CA) and anti-MUC2 (1:50; clone H300, sc-15334, Santa Cruz Biotechnology, Santa Cruz, CA). The sections were then incubated with a mixed solution of Alexa Fluor 488-conjugated second antibody (1:1000; goat anti-rabbit IgG or donkey anti-goat IgG, Life Technologies) and Alexa Fluor 555-conjugated streptavidin (1:1000; Life Technologies) for 1 h at room temperature. All tissues were mounted with SlowFade Diamond antifade reagent (Life Technologies) after nuclear staining with TO-PRO-3 (Life Technologies). To detect lysozyme and calnexin, the antigens were retrieved by boiling sections in 10 mM citrate buffer (pH 6) for 15 min before blocking. The specificity of the reaction was examined by omitting the lectins and primary antibodies. Images were obtained with an LSM510 confocal microscope (Carl Zeiss). 
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